EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hexokinase‐2 as a Therapeutic Target: Alleviating Herpes Simplex Keratitis Through Metabolic Reprogramming

Dan Jiang, Yining Sun, Xintong Yu, Ruoqi Wang, Yuting Zhang, Jinjie Yu, Shuang Xie, Yujia Cai, Yuhong Luo, Wei Chen iD

Advanced Science · 2025

DOI: 10.1002/advs.202503690 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Dan Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325000, China. Hauptthemen laut MEDLINE: Hexokinase, Keratitis, Herpetic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Program of Zhejiang Province, National Natural Science Foundation of China, Joint Research Program of Eye Research Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herpes simplex keratitis (HSK) is a leading infectious cause of blindness worldwide, with current therapies primarily targeting viral replication rather than addressing host‐cell injury. RNA sequencing of corneal tissue from HSK patients and healthy donors identifies a metabolic shift from mitochondrial oxidative phosphorylation to aerobic glycolysis. Notably, hexokinase‐2 (HK2), a pivotal glycolytic enzyme, exhibits the greatest up‐regulation, coinciding with a marked reduction in the activity of mitochondrial respiratory chain complexes in HSK corneas. Pharmacological inhibition of HK2 with lonidamine in human corneal epithelial cells reduces herpes simplex virus type 1 (HSV‐1) replication while preserving cell viability. In a murine model of HSK, topical lonidamine restored respiratory‐chain activity, lowered viral load, and accelerated corneal re‐epithelialization; its early therapeutic efficacy surpassed that of ganciclovir, and combination therapy conferred additive benefit. These findings identify HK2‐driven glycolytic reprogramming as a pathogenic hallmark of HSK and demonstrate that metabolic targeting concurrently restricts viral propagation and promotes tissue regeneration. Thus, metabolic intervention has the potential to complement direct antiviral therapy and represents a promising, clinically translatable strategy to preserve vision in HSK.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HexokinaseKeratitis, HerpeticAnimalsHumansMiceAntiviral AgentsGlycolysisVirus ReplicationHerpesvirus 1, HumanDisease Models, AnimalCorneaIndazolesMetabolic Reprogramming

Stichwörter der Autor:innen

herpes simplex keratitishexokinase‐2lonidaminemetabolismregeneration

Substanzen

HexokinaseAntiviral AgentsHK2 protein, humanlonidamineIndazoles

Autor:innen und Institutionen

  • National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325000, China.
  • State Key Laboratory of Ophthalmology, Optometry and Visual Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325000, China.
  • Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, 200000, China.
  • State Key Laboratory of Medical Genomics, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200000, China.
  • Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310000, China.

ORCID-Profile: Wei Chen

Förderung

  • Key Research and Development Program of Zhejiang Province
  • National Natural Science Foundation of China
  • Joint Research Program of Eye Research Center

Zitieren

APA

Jiang, D., Sun, Y., Yu, X., Wang, R., Zhang, Y., Yu, J., Xie, S., Cai, Y., Luo, Y., & Chen, W. (2025). Hexokinase‐2 as a Therapeutic Target: Alleviating Herpes Simplex Keratitis Through Metabolic Reprogramming. Advanced Science. https://doi.org/10.1002/advs.202503690

Vancouver

Jiang D, Sun Y, Yu X, Wang R, Zhang Y, Yu J, et al. Hexokinase‐2 as a Therapeutic Target: Alleviating Herpes Simplex Keratitis Through Metabolic Reprogramming. Advanced Science. 2025. doi:10.1002/advs.202503690

BibTeX
@article{Jiang2025,
  author = {Jiang, Dan and Sun, Yining and Yu, Xintong and Wang, Ruoqi and Zhang, Yuting and Yu, Jinjie and Xie, Shuang and Cai, Yujia and Luo, Yuhong and Chen, Wei},
  title = {Hexokinase‐2 as a Therapeutic Target: Alleviating Herpes Simplex Keratitis Through Metabolic Reprogramming},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202503690}
}
Kostenlos starten →